Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Apply
Trastuzumab Deruxtecan & Immunotherapy
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step